Much served as transaction counsel and key legal advisor to global clinical trial solutions provider Continuum Clinical in its sale to Spectrum Science. Continuum Clinical is an industry-leading developer of clinical trial recruitment and engagement services, providing fact-based patient registration services with a track record of exceeding enrollment targets on behalf of some of the world’s largest pharmaceutical companies.
Much principal Harlan Kahn counseled Continuum in the sale with support from attorneys David Pilotto, Reid Fulkerson, Julia Turk, Jeffrey London, and Tyler Bartholome, as well as paralegal Daisy Velasco.
“We’re very proud to be an integral part of uniting our client’s deep industry experience with a stellar organization and, in effect, helping develop one of the largest full-service clinical trial recruitment providers in the business,” Kahn said.
With this key acquisition, Spectrum Science will bolster its current offerings, including an elevated breadth of services and improved technological capabilities in the clinical trial engagement space.